Condition

GVHD - Graft-Versus-Host Disease clinical trials and research

• 7Clinical trials
• 6Countries

Newest GVHD - Graft-Versus-Host Disease clinical trials

All recruiting trials (7)

• Withaferin A to help prevent graft-versus-host disease after stem cell transplant

  This trial tests whether adding standardized Withaferin A to standard GvHD prevention can help people 18 and older with blood cancers who are getting a matched related donor stem cell transplant.

  Recruiting at 2 sites Phase 1/2 Tata Memorial Centre · Navi Mumbai, Maharashtra and 1 other locations · NCT07724873

• Standardized Withaferin A for steroid-refractory acute GVHD after stem cell transplant

  This study tests whether a standardized extract of Withania somnifera (Withaferin A) given by mouth can help patients with steroid-refractory acute GVHD after an allogeneic stem cell transplant.

  Recruiting Phase 2 Tata Memorial Centre · Navi Mumbai, Maharashtra · NCT07708987

• Post transplant cyclophosphamide, bortezomib, and sitagliptin to prevent graft-versus-host disease after allogeneic transplantation

  This study tests whether a combination of post-transplant cyclophosphamide, bortezomib, and sitagliptin can prevent GvHD in adults undergoing reduced-intensity allogeneic stem cell transplantation from matched related or unrelated donors.

  Recruiting Phase 1/2 Northwell Health · New Hyde Park, New York · NCT07675174

• Psychiatric Symptoms and Quality of Life in Graft-versus-Host Disease

  This project will see if psychiatric symptoms like depression are linked to GvHD symptom severity and health-related quality of life in adults with graft-versus-host disease.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07314892

• Lowering the total dose of cyclophosphamide after haploidentical stem cell transplant for blood cancers

  This trial tests whether a reduced total dose of cyclophosphamide after a haploidentical stem cell transplant can improve outcomes for adults with blood cancers.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT07193420

• Comparing Ruxolitinib with Steroids for Chronic Graft-versus-Host Disease Treatment

  This study is testing if a new treatment combining Ruxolitinib with steroids can help people with moderate to severe chronic graft-versus-host disease feel better compared to just using steroids alone.

  Recruiting Phase 2 Seoul St. Mary's Hospital · Seoul, Banpo-daero/Seocho-gu · NCT06756061

• Monitoring blood conditions after stem cell transplantation using cell-free DNA analysis

  This study is testing if analyzing cell-free DNA from blood samples can help doctors better monitor and diagnose complications like infections and graft-versus-host disease in patients who have received a stem cell transplant.

  Recruiting at 2 sites University of Turin, Italy · Milan, Milan and 1 other locations · NCT06715046

Related topics

Quick answers

How many GVHD - Graft-Versus-Host Disease clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in India (2 trials), Italy (1 trial), France (1 trial), Poland (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →